MBIO
Mustang Bio Inc
NASDAQ: MBIO · HEALTHCARE · BIOTECHNOLOGY
$0.75
-0.66% today
Updated 2026-04-29
Market cap
$5.68M
P/E ratio
—
P/S ratio
2,205.73x
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$1 – $4
Volume
0.0M
Mustang Bio Inc (MBIO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-67.90%
ROA
-11.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $0.00 | $-4.47M | — | — | — |
| 2016 | $0.00 | $-12.65M | — | — | — |
| 2017 | $0.00 | $-31.29M | — | — | — |
| 2018 | $0.00 | $-30.66M | — | — | — |
| 2019 | $0.00 | $-48.16M | — | — | — |
| 2020 | $0.00 | $-60.02M | — | — | — |
| 2021 | $0.00 | $-66.37M | — | — | — |
| 2022 | $0.00 | $-77.53M | — | — | — |
| 2023 | $0.00 | $-51.60M | — | — | — |
| 2024 | $0.00 | $-15.75M | — | — | — |
| 2025 | $0.00 | $-1.92M | — | — | — |